|
*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, Frankly and this Station make no warranties or representations in connection therewith.
|
Medicine & Pharmaceuticals News Releases via PRNewswireMore>>
Molecular Biology Enzymes and Kits and Reagents Market Worth $26.7 Billion by 2025: Grand View Research, Inc.
Molecular Biology Enzymes and Kits and Reagents Market Worth $26.7 Billion by 2025: Grand View Research, Inc.
The global molecular biology enzymes and kits & reagents market is expected to reach USD 26.7 billion by 2025, according to a new report by Grand View Research, Inc. Expanding pharmaceutical and biotechnology industry...More \232aThe global molecular biology enzymes and kits & reagents market is expected to reach USD 26.7 billion by 2025, according to a new report by Grand View Research, Inc. Expanding pharmaceutical and biotechnology industry...More \232aARMO BioSciences Presents Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer at ESMO World Congress on Gastrointestinal Cancer 2017
ARMO BioSciences Presents Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer at ESMO World Congress on Gastrointestinal Cancer 2017
ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at the ESMO 19th World Congress...More \232aARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at the ESMO 19th World Congress...More \232aHeptares and PeptiDream Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Therapeutics in Inflammatory Disease
Heptares and PeptiDream Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Therapeutics in Inflammatory Disease
Heptares Therapeutics ("Heptares"), a wholly owned subsidiary of Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), and PeptiDream Inc., a public Tokyo-based biopharmaceutical company ("PeptiDream"; TOKYO: 4587),...More \232aHeptares Therapeutics ("Heptares"), a wholly owned subsidiary of Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), and PeptiDream Inc., a public Tokyo-based biopharmaceutical company ("PeptiDream"; TOKYO: 4587),...More \232aZai Lab Secures Series C Financing
Zai Lab Secures Series C Financing
Zai Lab Limited, a Shanghai-based innovative biopharmaceutical company focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical needs in the...More \232aZai Lab Limited, a Shanghai-based innovative biopharmaceutical company focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical needs in the...More \232aU.S. Senator Cory Gardner Agrees With Colorado Voters: Kids Are A Priority
U.S. Senator Cory Gardner Agrees With Colorado Voters: Kids Are A Priority
A recent poll conducted by a leading Republican pollster finds a "universal belief" among Colorado voters across the political spectrum that regardless of what happens with the proposed healthcare bill, longstanding...More \232aA recent poll conducted by a leading Republican pollster finds a "universal belief" among Colorado voters across the political spectrum that regardless of what happens with the proposed healthcare bill, longstanding...More \232aBlink Health Giving Away $10 Million Worth Of Free Diabetes Medications
Blink Health Giving Away $10 Million Worth Of Free Diabetes Medications
Blink Health, America's leading prescription drug savings platform, recently launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of diabetes medications. People living with...More \232aBlink Health, America's leading prescription drug savings platform, recently launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of diabetes medications. People living with...More \232aLow Uptake of Cancer Preventing Human Papillomavirus Vaccine Linked to Lasting Injection Fear Formed in Preschool
Low Uptake of Cancer Preventing Human Papillomavirus Vaccine Linked to Lasting Injection Fear Formed in Preschool
Dr. Amy Baxter, CEO of noninvasive pain relief leader MMJ Labs, published a study demonstrating a new factor influencing teens' decision to vaccinate. "The number of injected same-day preschool vaccines relates to...More \232aDr. Amy Baxter, CEO of noninvasive pain relief leader MMJ Labs, published a study demonstrating a new factor influencing teens' decision to vaccinate. "The number of injected same-day preschool vaccines relates to...More \232aWunnumin Lake First Nation receives funding for health services
Wunnumin Lake First Nation receives funding for health services
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliatedMore \232aInformation contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliatedMore \232aRedbud Labs announces MXR, enables 10x faster molecular assays
Redbud Labs announces MXR, enables 10x faster molecular assays
Redbud Labs has released MXR, a microfluidic chip that accelerates molecular assays by up to 10x. Designed specifically for diagnostic consumables, MXR can be added to virtually any cartridge design.More \232aRedbud Labs has released MXR, a microfluidic chip that accelerates molecular assays by up to 10x. Designed specifically for diagnostic consumables, MXR can be added to virtually any cartridge design.More \232aGlobal Hernia Repair Devices Market 2017-2021: Increasing Popularity of Robot-assisted Surgeries in Hernia Repair
Global Hernia Repair Devices Market 2017-2021: Increasing Popularity of Robot-assisted Surgeries in Hernia Repair
Research and Markets has announced the addition of the "Global Hernia Repair Devices Market 2017-2021" report to their offering. The global hernia repair devices market to grow at a CAGR of 5.74% during the period...More \232aResearch and Markets has announced the addition of the "Global Hernia Repair Devices Market 2017-2021" report to their offering. The global hernia repair devices market to grow at a CAGR of 5.74% during the period...More \232aGlobal Blood Gas Analyzers Market 2017-2021 - Adoption of Standardization and Automation Across the In-Vitro Diagnostics Industry
Global Blood Gas Analyzers Market 2017-2021 - Adoption of Standardization and Automation Across the In-Vitro Diagnostics Industry
Research and Markets has announced the addition of the "Global Blood Gas Analyzers Market 2017-2021" report to their offering. The global blood gas analyzers market to grow at a CAGR of 6.28% during the period 2017-2021. ...More \232aResearch and Markets has announced the addition of the "Global Blood Gas Analyzers Market 2017-2021" report to their offering. The global blood gas analyzers market to grow at a CAGR of 6.28% during the period 2017-2021. ...More \232aAbdominal Surgical Robots - Markets Reach $15.8 Billion By 2023
Abdominal Surgical Robots - Markets Reach $15.8 Billion By 2023
Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Abdominal Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide - 2017-2023" to their offering. The worldwide...More \232aResearch and Markets has announced the addition of Wintergreen Research, Inc's new report "Abdominal Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide - 2017-2023" to their offering. The worldwide...More \232aTo Avoid Mosquitoes: Get Smart!
To Avoid Mosquitoes: Get Smart!
With temperatures rising and more people heading outdoors for summer fun, the mosquito experts from the SC Johnson Institute of Insect Science for Family Health – one of the world's largest private, urban entomology...More \232aWith temperatures rising and more people heading outdoors for summer fun, the mosquito experts from the SC Johnson Institute of Insect Science for Family Health – one of the world's largest private, urban entomology...More \232aGlobal Hepatitis Drug Market & Clinical Trials Insight 2023: Introduction of Generic Drugs Has Changed Market Dynamics
Global Hepatitis Drug Market & Clinical Trials Insight 2023: Introduction of Generic Drugs Has Changed Market Dynamics
Research and Markets has announced the addition of the "Global Hepatitis Drug Market & Clinical Trials Insight 2023" report to their offering. The global hepatitis drug market is expected to surpass USD 70 Billion by...More \232aResearch and Markets has announced the addition of the "Global Hepatitis Drug Market & Clinical Trials Insight 2023" report to their offering. The global hepatitis drug market is expected to surpass USD 70 Billion by...More \232aSenzaGen signs global distribution agreement with Charles River Laboratories
SenzaGen signs global distribution agreement with Charles River Laboratories
SenzaGen announces today that the company has signed a global distribution agreement with Charles River Laboratories, a leading early-stage contract research organization, to market GARDskin to their clients globally....More \232aSenzaGen announces today that the company has signed a global distribution agreement with Charles River Laboratories, a leading early-stage contract research organization, to market GARDskin to their clients globally....More \232aRelmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program
Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program
Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Dr. Maurizio Fava has been named chair of the...More \232aRelmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Dr. Maurizio Fava has been named chair of the...More \232aAdicet Bio Appoints Jesse McGreivy, M.D., Chief Medical Officer
Adicet Bio Appoints Jesse McGreivy, M.D., Chief Medical Officer
Adicet Bio, Inc. ("Adicet"), a biopharmaceutical company focused on the development of next-generation immunotherapies, announced today that it has appointed Jesse McGreivy, M.D. as its Chief Medical Officer. Dr. McGreivy...More \232aAdicet Bio, Inc. ("Adicet"), a biopharmaceutical company focused on the development of next-generation immunotherapies, announced today that it has appointed Jesse McGreivy, M.D. as its Chief Medical Officer. Dr. McGreivy...More \232aShriners Hospitals for Children races into their 95th anniversary celebration with NASCAR driver David Ragan in the Coke Zero 400 at Daytona International Speedway
Shriners Hospitals for Children races into their 95th anniversary celebration with NASCAR driver David Ragan in the Coke Zero 400 at Daytona International Speedway
Shriners Hospitals for Children® will celebrate 95 years of caring for kids with a specially-designed racecar in the Coke Zero 400 at Daytona International Speedway this Saturday, July 1, 2017. David Ragan's No. 38...More \232aShriners Hospitals for Children® will celebrate 95 years of caring for kids with a specially-designed racecar in the Coke Zero 400 at Daytona International Speedway this Saturday, July 1, 2017. David Ragan's No. 38...More \232aCanopy Biosciences Launches Service to Simultaneously Analyze >700 Genes in a Single Sample
Canopy Biosciences Launches Service to Simultaneously Analyze >700 Genes in a Single Sample
Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it has launched a service for high throughput gene expression analysis. Based on the NanoString...More \232aCanopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it has launched a service for high throughput gene expression analysis. Based on the NanoString...More \232aLuminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay
Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay
Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for the ARIES® Norovirus Assay, an easy to use, sample to answer test for rapid detection and differentiation of norovirus genogroup I...More \232aLuminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for the ARIES® Norovirus Assay, an easy to use, sample to answer test for rapid detection and differentiation of norovirus genogroup I...More \232aUfirst's 'Nuguna Neckband', The First Environmental Awareness Device Launches Successfully on Kickstarter
Ufirst's 'Nuguna Neckband', The First Environmental Awareness Device Launches Successfully on Kickstarter
Ufirst (CEO Fedora Lee) released the world's first environmental awareness device, 'NUGUNA Neckband', on June 22, 2017, on Kickstarter. In just three days, 'NUGUNA Neckband' has exceeded its funding...More \232aUfirst (CEO Fedora Lee) released the world's first environmental awareness device, 'NUGUNA Neckband', on June 22, 2017, on Kickstarter. In just three days, 'NUGUNA Neckband' has exceeded its funding...More \232aAudentes Therapeutics Announces Participation in Upcoming Investor Conferences
Audentes Therapeutics Announces Participation in Upcoming Investor Conferences
Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced its...More \232aAudentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced its...More \232aGenePOC annonce un accord de distribution exclusif avec Cardinal Health pour le marché américain
GenePOC annonce un accord de distribution exclusif avec Cardinal Health pour le marché américain
GenePOC annonce qu'avec la signature d'une entente de distribution exclusive, Cardinal Health devient son partenaire commercial pour couvrir le marché américain GenePOC, Inc. (GenePOC), membre de...More \232aGenePOC annonce qu'avec la signature d'une entente de distribution exclusive, Cardinal Health devient son partenaire commercial pour couvrir le marché américain GenePOC, Inc. (GenePOC), membre de...More \232aGenePOC Announces an Exclusive Distribution Agreement with Cardinal Health Covering the US Market
GenePOC Announces an Exclusive Distribution Agreement with Cardinal Health Covering the US Market
GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce that it has signed an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States to sell the...More \232aGenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce that it has signed an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States to sell the...More \232aAmerican Cleft Palate-Craniofacial Association to Merge with Cleft Palate Foundation
American Cleft Palate-Craniofacial Association to Merge with Cleft Palate Foundation
The American Cleft Palate-Craniofacial Association (ACPA) and the Cleft Palate Foundation (CPF), two nonprofit organizations dedicated to the treatment of cleft palate and other craniofacial conditions, will merge...More \232aThe American Cleft Palate-Craniofacial Association (ACPA) and the Cleft Palate Foundation (CPF), two nonprofit organizations dedicated to the treatment of cleft palate and other craniofacial conditions, will merge...More \232aResverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modification.More \232aA data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modification.More \232aDaily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma
Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma
If you want a Stock Review on APRI, DRRX, SCMP or SCLN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com shifts focus on four Drug...More \232aIf you want a Stock Review on APRI, DRRX, SCMP or SCLN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com shifts focus on four Drug...More \232aMichael C. Joiner, Ph.D., of Karmanos Cancer Institute and WSU, to receive Lifetime Achievement Award from European Society of Radiotherapy and Oncology
Michael C. Joiner, Ph.D., of Karmanos Cancer Institute and WSU, to receive Lifetime Achievement Award from European Society of Radiotherapy and Oncology
Michael C. Joiner, Ph.D., professor in the Division of Radiation Oncology, Department of Oncology, at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, will be honoured by the...More \232aMichael C. Joiner, Ph.D., professor in the Division of Radiation Oncology, Department of Oncology, at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, will be honoured by the...More \232aHeptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine
Heptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine
New programme focused on key GPCR target implicated in aggressive brain cancer Heptares Therapeutics ("Heptares"), the wholly-owned subsidiary of Sosei Group Corporation (TSE Mothers Index: 4565), announces the launch...More \232aNew programme focused on key GPCR target implicated in aggressive brain cancer Heptares Therapeutics ("Heptares"), the wholly-owned subsidiary of Sosei Group Corporation (TSE Mothers Index: 4565), announces the launch...More \232aParkinson's Disease Patients are First to be Treated With Elekta's New Leksell Vantage Stereotactic System
Parkinson's Disease Patients are First to be Treated With Elekta's New Leksell Vantage Stereotactic System
Elekta (EKTA-B.ST) today announced that its Leksell®Vantage™ Stereotactic System is now in clinical use at three European centers. The first surgeries were performed on a patient with Parkinson's disease at the...More \232aElekta (EKTA-B.ST) today announced that its Leksell®Vantage™ Stereotactic System is now in clinical use at three European centers. The first surgeries were performed on a patient with Parkinson's disease at the...More \232aPMD Healthcare Supports Bone Marrow Transplant Study
PMD Healthcare Supports Bone Marrow Transplant Study
In 2003, Matthew W was diagnosed with Stage-3 Hodgkin's Lymphoma at age 15, a cancer that attacks the body's immune system. After being treated with chemotherapy and radiation, he was cancer free but suffered two...More \232aIn 2003, Matthew W was diagnosed with Stage-3 Hodgkin's Lymphoma at age 15, a cancer that attacks the body's immune system. After being treated with chemotherapy and radiation, he was cancer free but suffered two...More \232aMerus Labs International Inc. Mails Letter to Shareholders with Reminder to Vote FOR the Proposed Arrangement with Norgine B.V. by deadline of 10:00 AM (Toronto time) July 6, 2017, and Receives Positive Recommendation in Favour of the Arrangement from Ind
Merus Labs International Inc. Mails Letter to Shareholders with Reminder to Vote FOR the Proposed Arrangement with Norgine B.V. by deadline of 10:00 AM (Toronto time) July 6, 2017, and Receives Positive Recommendation in Favour of the Arrangement from Ind
TORONTO, June 27, 2017 /PRNewswire/ - Merus Labs International Inc. (TSX: MSL, NASDAQ: MSLI) ("Merus" or the "Company") announced today that it has mailed a letter to Merus shareholders ("Shareholders") reminding...More \232aTORONTO, June 27, 2017 /PRNewswire/ - Merus Labs International Inc. (TSX: MSL, NASDAQ: MSLI) ("Merus" or the "Company") announced today that it has mailed a letter to Merus shareholders ("Shareholders") reminding...More \232aTherapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28
Therapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28
Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix"), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that the Company will ring The Nasdaq...More \232aTherapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix"), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that the Company will ring The Nasdaq...More \232aMirati Therapeutics Announces Appointment Of Neil Reisman To The Board Of Directors
Mirati Therapeutics Announces Appointment Of Neil Reisman To The Board Of Directors
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, today announced the appointment of Neil Reisman to the Company's Board of Directors, effective immediately.More \232aMirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, today announced the appointment of Neil Reisman to the Company's Board of Directors, effective immediately.More \232aThe Lieber Institute for Brain Development Discovers an Innovative Approach to Improve Genomic Data in the Human Brain
The Lieber Institute for Brain Development Discovers an Innovative Approach to Improve Genomic Data in the Human Brain
A recent paper published in the Proceedings of the National Academy of Sciences (PNAS) provides researchers with an improved approach for correcting bias in studies that examine RNA sequences to better understand gene...More \232aA recent paper published in the Proceedings of the National Academy of Sciences (PNAS) provides researchers with an improved approach for correcting bias in studies that examine RNA sequences to better understand gene...More \232aThree giants in the field of radiation oncology named 2017 ASTRO Gold Medalists
Three giants in the field of radiation oncology named 2017 ASTRO Gold Medalists
The American Society for Radiation Oncology (ASTRO) is pleased to announce the 2017 ASTRO Gold Medalists. Søren M. Bentzen, DSc, PhD; Louis B. Harrison, MD, FASTRO; and Michael L. Steinberg, MD, FASTRO, have been awarded...More \232aThe American Society for Radiation Oncology (ASTRO) is pleased to announce the 2017 ASTRO Gold Medalists. Søren M. Bentzen, DSc, PhD; Louis B. Harrison, MD, FASTRO; and Michael L. Steinberg, MD, FASTRO, have been awarded...More \232aGreat Place to Work® and FORTUNE name Roche Diagnostics one of the Best Workplaces for Millennials
Great Place to Work® and FORTUNE name Roche Diagnostics one of the Best Workplaces for Millennials
Roche Diagnostics was named as #67 on the list of the country's Best Workplaces for Millennials, announced by research and consulting firm Great Place to Work and FORTUNE.More \232aRoche Diagnostics was named as #67 on the list of the country's Best Workplaces for Millennials, announced by research and consulting firm Great Place to Work and FORTUNE.More \232aNew Jersey Health Foundation Supports Rutgers TechAdvance Fund With $500,000 Commitment; Encourages Others to Follow Lead
New Jersey Health Foundation Supports Rutgers TechAdvance Fund With $500,000 Commitment; Encourages Others to Follow Lead
New Jersey Health Foundation (NJHF) made its first $100,000 contribution on a $500,000 pledge over five years to support the new Rutgers University TechAdvance Fund, a program intended to advance Rutgers technologies...More \232aNew Jersey Health Foundation (NJHF) made its first $100,000 contribution on a $500,000 pledge over five years to support the new Rutgers University TechAdvance Fund, a program intended to advance Rutgers technologies...More \232a2017 Donate Life ECHO Focuses on the Importance of Donation and Transplantation in Multicultural Communities
2017 Donate Life ECHO Focuses on the Importance of Donation and Transplantation in Multicultural Communities
Multicultural communities are disproportionately in need of lifesaving organ transplants – especially kidneys. Currently, 58 percent of the U.S. transplant waiting list is comprised of ethnically diverse patients. To...More \232aMulticultural communities are disproportionately in need of lifesaving organ transplants – especially kidneys. Currently, 58 percent of the U.S. transplant waiting list is comprised of ethnically diverse patients. To...More \232aDr. Joan Fallon, CEO of Curemark, Named EY Entrepreneur Of The Year® 2017 New York Award Winner
Dr. Joan Fallon, CEO of Curemark, Named EY Entrepreneur Of The Year® 2017 New York Award Winner
Curemark announced that CEO Dr. Joan Fallon received the EY Entrepreneur Of The Year 2017 NY Award in the Healthcare category. The award recognizes entrepreneurs who are excelling in areas such as innovation, financial...More \232aCuremark announced that CEO Dr. Joan Fallon received the EY Entrepreneur Of The Year 2017 NY Award in the Healthcare category. The award recognizes entrepreneurs who are excelling in areas such as innovation, financial...More \232aCCRM to Open State-of-the-Art Fertility Clinic in San Francisco Bay Area
CCRM to Open State-of-the-Art Fertility Clinic in San Francisco Bay Area
Committed to expanding access to the highest quality of fertility care available, the CCRM Network is opening a new location in the San Francisco Bay Area on June 28. CCRM San Francisco is co-founded by board certified...More \232aCommitted to expanding access to the highest quality of fertility care available, the CCRM Network is opening a new location in the San Francisco Bay Area on June 28. CCRM San Francisco is co-founded by board certified...More \232aGeisinger names Karen Murphy Executive Vice President and Chief Innovation Officer
Geisinger names Karen Murphy Executive Vice President and Chief Innovation Officer
Karen Murphy, RN, PhD, Secretary of Health in Pennsylvania, has been named Executive Vice President, Chief Innovation Officer and Founding Director of the Steele Institute for Healthcare Innovation at Geisinger. She will...More \232aKaren Murphy, RN, PhD, Secretary of Health in Pennsylvania, has been named Executive Vice President, Chief Innovation Officer and Founding Director of the Steele Institute for Healthcare Innovation at Geisinger. She will...More \232aFight Colorectal Cancer Launches Biomarked to Educate on the Role of Biomarkers in Cancer Treatment
Fight Colorectal Cancer Launches Biomarked to Educate on the Role of Biomarkers in Cancer Treatment
Today, Fight Colorectal Cancer (Fight CRC), the leading patient advocacy group in colorectal cancer, kicked-off Biomarked, with support from Eli Lilly and Company, to shine a spotlight on genetic biomarkers and the...More \232aToday, Fight Colorectal Cancer (Fight CRC), the leading patient advocacy group in colorectal cancer, kicked-off Biomarked, with support from Eli Lilly and Company, to shine a spotlight on genetic biomarkers and the...More \232aThe Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health Hackensack University Medical Center Ranks 45 in Pediatric Neurology and Neurosurgery in U.S. News & World Report 2017-18 Best Children's Hospitals
The Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health Hackensack University Medical Center Ranks 45 in Pediatric Neurology and Neurosurgery in U.S. News & World Report 2017-18 Best Children's Hospitals
U.S. News & World Report has ranked Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health Hackensack University Medical Center in pediatric neurology and neurosurgery specialties in the new 2017-18...More \232aU.S. News & World Report has ranked Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health Hackensack University Medical Center in pediatric neurology and neurosurgery specialties in the new 2017-18...More \232aLandmark Health Extends Medical House Calls to More Patients
Landmark Health Extends Medical House Calls to More Patients
Landmark Health announces today their latest initiative to expand their home-based medical program to reach more people in need of high-touch care. Landmark Connect provides primary care to residents living in skilled...More \232aLandmark Health announces today their latest initiative to expand their home-based medical program to reach more people in need of high-touch care. Landmark Connect provides primary care to residents living in skilled...More \232aSurvey Shows Intensifying Focus on Cost and Demonstration of Value in Increasingly Competitive Orphan Drug Space
Survey Shows Intensifying Focus on Cost and Demonstration of Value in Increasingly Competitive Orphan Drug Space
Decision Resources Group finds that more than 40% of surveyed U.S. physicians perceive an increase over the last three years in the degree of payer challenges they face when prescribing for rare diseases. Separately, the...More \232aDecision Resources Group finds that more than 40% of surveyed U.S. physicians perceive an increase over the last three years in the degree of payer challenges they face when prescribing for rare diseases. Separately, the...More \232aDance Biopharm Appoints Steve Thornton to Board of Directors
Dance Biopharm Appoints Steve Thornton to Board of Directors
Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled insulin product to treat diabetes, is pleased to announce...More \232aDance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled insulin product to treat diabetes, is pleased to announce...More \232aEmmes Ranked as a Top Area Workplace for Second Consecutive Year by The Washington Post
Emmes Ranked as a Top Area Workplace for Second Consecutive Year by The Washington Post
The Emmes Corporation today announced that it was selected as one of the best places to work in the greater Washington area. The Washington Post's 2017 Top Workplaces list ranked private, public, nonprofit and...More \232aThe Emmes Corporation today announced that it was selected as one of the best places to work in the greater Washington area. The Washington Post's 2017 Top Workplaces list ranked private, public, nonprofit and...More \232aMiracle Flights Announces Record-Setting Year for Free Medical Flights
Miracle Flights Announces Record-Setting Year for Free Medical Flights
Miracle Flights, the nation's leading medical flight charity, announced today a record number of flights performed for its fiscal year ending April 30, 2017. The Las Vegas-based nonprofit provides free commercial air...More \232aMiracle Flights, the nation's leading medical flight charity, announced today a record number of flights performed for its fiscal year ending April 30, 2017. The Las Vegas-based nonprofit provides free commercial air...More \232aNetDirector Streamlines Patient Experience in Healthcare with New Health Logix Integration Suite
NetDirector Streamlines Patient Experience in Healthcare with New Health Logix Integration Suite
NetDirector, a cloud-based data exchange and integration platform, continues to expand the presence of their cloud-based integration-platform-as-a-service (iPaaS) in the healthcare industry. In their most recent...More \232aNetDirector, a cloud-based data exchange and integration platform, continues to expand the presence of their cloud-based integration-platform-as-a-service (iPaaS) in the healthcare industry. In their most recent...More \232aOramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog Capsule
Oramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog Capsule
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office...More \232aOramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office...More \232aGlobal High-density Multiplexed Diagnostic Assays Market to Grow at a CAGR of 15% During 2017-2021 - Key Vendors are Thermo Fisher Scientific, Abbott & F. Hoffmann-La Roche
Global High-density Multiplexed Diagnostic Assays Market to Grow at a CAGR of 15% During 2017-2021 - Key Vendors are Thermo Fisher Scientific, Abbott & F. Hoffmann-La Roche
Research and Markets has announced the addition of the "Global High-density Multiplexed Diagnostic Assays Market 2017-2021" report to their offering. The global high density multiplexed diagnostic assays market to grow...More \232aResearch and Markets has announced the addition of the "Global High-density Multiplexed Diagnostic Assays Market 2017-2021" report to their offering. The global high density multiplexed diagnostic assays market to grow...More \232aMedial EarlySign Partners With Medicover on New EU Pilot Project to Identify Patients at Risk of Harboring Colorectal Cancer
Medial EarlySign Partners With Medicover on New EU Pilot Project to Identify Patients at Risk of Harboring Colorectal Cancer
Medial EarlySign (earlysign.com), a developer of machine learning tools for data driven medicine, today announced a strategic collaboration with Medicover, a leading international healthcare and diagnostic services...More \232aMedial EarlySign (earlysign.com), a developer of machine learning tools for data driven medicine, today announced a strategic collaboration with Medicover, a leading international healthcare and diagnostic services...More \232aBlueRock Therapeutics Announces Key Members of Executive Team
BlueRock Therapeutics Announces Key Members of Executive Team
BlueRock Therapeutics today announced a trio of hires that bolster the company's strategic and operational capabilities to develop breakthrough cell therapies for degenerative diseases such as Parkinson's and heart...More \232aBlueRock Therapeutics today announced a trio of hires that bolster the company's strategic and operational capabilities to develop breakthrough cell therapies for degenerative diseases such as Parkinson's and heart...More \232aTexas Children's Hospital ranks 4th nationally among all children's hospitals by U.S. News & World Report
Texas Children's Hospital ranks 4th nationally among all children's hospitals by U.S. News & World Report
Texas Children's Hospital continues to earn national recognition as a leader in pediatric health care, ranking fourth among the nearly 200 pediatric centers surveyed by U.S. News & World Report in their 2017-18...More \232aTexas Children's Hospital continues to earn national recognition as a leader in pediatric health care, ranking fourth among the nearly 200 pediatric centers surveyed by U.S. News & World Report in their 2017-18...More \232aAkonni Biosystems Elects Brian J. Morra as Executive Chairman of the Board
Akonni Biosystems Elects Brian J. Morra as Executive Chairman of the Board
Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced the election of Mr. Brian J. Morra as the company's Executive Chairman...More \232aAkonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced the election of Mr. Brian J. Morra as the company's Executive Chairman...More \232a3D Printing Medical Devices Market Size is Projected to be Around $9.8 Billion by 2025 - Market Research Globe
3D Printing Medical Devices Market Size is Projected to be Around $9.8 Billion by 2025 - Market Research Globe
A research study titled, "3D Printing Medical Devices Market by Component, Technology, Application, and End User - Global Industry Analysis and Forecast to 2025" published by Crystal Market Research, states that the 3D...More \232aA research study titled, "3D Printing Medical Devices Market by Component, Technology, Application, and End User - Global Industry Analysis and Forecast to 2025" published by Crystal Market Research, states that the 3D...More \232aDigital PCR and Real-time PCR (qPCR) Market Worth 5.31 Billion USD by 2022
Digital PCR and Real-time PCR (qPCR) Market Worth 5.31 Billion USD by 2022
According to a new market research report "Digital PCR and Real-time PCR (qPCR) Market by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research,...More \232aAccording to a new market research report "Digital PCR and Real-time PCR (qPCR) Market by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research,...More \232aBerkeley Lights Announces Cell Line Development Program
Berkeley Lights Announces Cell Line Development Program
Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today a pilot cell line development program with Shire. Under the program, BLI...More \232aBerkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today a pilot cell line development program with Shire. Under the program, BLI...More \232aJust Announced: ExL Events Presents the First and Only Life Science Investor Relations Forum. Join Us September 7-8, 2017 in Boston, for This Unparalleled Event.
Just Announced: ExL Events Presents the First and Only Life Science Investor Relations Forum. Join Us September 7-8, 2017 in Boston, for This Unparalleled Event.
ExL Events has just announced the industry's first annual Life Science Investor Relations Forum, hosted on September 7–8, 2017 in Boston, MA. This inaugural event will bring together IR professionals to address the...More \232aExL Events has just announced the industry's first annual Life Science Investor Relations Forum, hosted on September 7–8, 2017 in Boston, MA. This inaugural event will bring together IR professionals to address the...More \232aBiostage Announces Agreement to Conduct $3.1 Million Private Placement at Market
Biostage Announces Agreement to Conduct $3.1 Million Private Placement at Market
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea,...More \232aBiostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea,...More \232aSpherix Issues Letter to Shareholders
Spherix Issues Letter to Shareholders
Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders.More \232aSpherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders.More \232aTrovagene Announces Submission of Investigational New Drug Application to Initiate Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia
Trovagene Announces Submission of Investigational New Drug Application to Initiate Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia
Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to conduct a Phase...More \232aTrovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to conduct a Phase...More \232aCancer Moonshot: One Year Later Summit to Celebrate Progress & Identify Gaps in Cancer Care
Cancer Moonshot: One Year Later Summit to Celebrate Progress & Identify Gaps in Cancer Care
Amid proposed federal government budget cuts, more than 250 cancer researchers, medical professionals, policymakers, patients, caregivers, survivors, and advocates will convene in Washington, D.C. today for Cancer...More \232aAmid proposed federal government budget cuts, more than 250 cancer researchers, medical professionals, policymakers, patients, caregivers, survivors, and advocates will convene in Washington, D.C. today for Cancer...More \232aOncolytics Biotech® Inc. Opens U.S. Based Office in San Diego
Oncolytics Biotech® Inc. Opens U.S. Based Office in San Diego
CALGARY and SAN DIEGO, June 27, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company) today announced that it has opened an office in San Diego, California. The office will...More \232aCALGARY and SAN DIEGO, June 27, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company) today announced that it has opened an office in San Diego, California. The office will...More \232aSynthetic Biologics Announces Allowance of Key U.S. Patent Covering SYN-010 Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
Synthetic Biologics Announces Allowance of Key U.S. Patent Covering SYN-010 Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that the U.S. Patent and...More \232aSynthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that the U.S. Patent and...More \232aMEA Parenteral Nutrition Market Analysis and Segment Forecasts, 2014-2017 & 2025 - Single Dose Amino Acid Solutions Held a Dominant Share in 2016 - Research and Markets
MEA Parenteral Nutrition Market Analysis and Segment Forecasts, 2014-2017 & 2025 - Single Dose Amino Acid Solutions Held a Dominant Share in 2016 - Research and Markets
Research and Markets has announced the addition of the "MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solution, Trace Elements, Vitamins...More \232aResearch and Markets has announced the addition of the "MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solution, Trace Elements, Vitamins...More \232aOWC Pharmaceutical Research Corp. Announces Market Readiness of its Cannabinoid-based Topical Cream for Skin Conditions Starting With Psoriasis
OWC Pharmaceutical Research Corp. Announces Market Readiness of its Cannabinoid-based Topical Cream for Skin Conditions Starting With Psoriasis
OWC Pharmaceutical Research Corp. (OTCQB: OWCP) today announced that its wholly-owned, Israel-based subsidiary, One World Cannabis Ltd. (OWC), has filed a patent application with the United States Patent and Trademark...More \232aOWC Pharmaceutical Research Corp. (OTCQB: OWCP) today announced that its wholly-owned, Israel-based subsidiary, One World Cannabis Ltd. (OWC), has filed a patent application with the United States Patent and Trademark...More \232aDaily Technical Summary Reports on Biotech Stocks -- Concordia, Cytokinetics, Dermira, and Endocyte
Daily Technical Summary Reports on Biotech Stocks -- Concordia, Cytokinetics, Dermira, and Endocyte
If you want a Stock Review on CXRX, CYTK, DERM or ECYT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com reviews the Biotechnology sector,...More \232aIf you want a Stock Review on CXRX, CYTK, DERM or ECYT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com reviews the Biotechnology sector,...More \232aResearch and Markets - Global Dermatoscopes Market to Grow at a CAGR of 8.8% by 2021 - Key Vendors are Canfield Scientific, Dermlite, FotoFinder Systems, HEINE Optotechnik & Optilia Instruments
Research and Markets - Global Dermatoscopes Market to Grow at a CAGR of 8.8% by 2021 - Key Vendors are Canfield Scientific, Dermlite, FotoFinder Systems, HEINE Optotechnik & Optilia Instruments
Research and Markets has announced the addition of the "Global Dermatoscopes Market 2017-2021" report to their offering. The global dermatoscopes market to grow at a CAGR of 8.89% during the period 2017-2021. The...More \232aResearch and Markets has announced the addition of the "Global Dermatoscopes Market 2017-2021" report to their offering. The global dermatoscopes market to grow at a CAGR of 8.89% during the period 2017-2021. The...More \232aCanopy Growth Corporation Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Positioning for 2018
Canopy Growth Corporation Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Positioning for 2018
Development of regulated legal cannabis markets in Canada and abroad just beginning in areas of consumer products, distribution, research and vertical integrationMore \232aDevelopment of regulated legal cannabis markets in Canada and abroad just beginning in areas of consumer products, distribution, research and vertical integrationMore \232aMore Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention
More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention
America's biopharmaceutical companies are continuing the fight to conquer the human immunodeficiency virus (HIV), which can develop into acquired immune deficiency syndrome (AIDS), with 52 medicines and vaccines...More \232aAmerica's biopharmaceutical companies are continuing the fight to conquer the human immunodeficiency virus (HIV), which can develop into acquired immune deficiency syndrome (AIDS), with 52 medicines and vaccines...More \232aZander Therapeutics Inc. Announces Brian Devine, Former Chairman of PETCO, to Helm its Business Advisory Board
Zander Therapeutics Inc. Announces Brian Devine, Former Chairman of PETCO, to Helm its Business Advisory Board
Brian Devine, retired Chairman of PETCO, a leading pet specialty retailer, has agreed to serve as Chairman of the Business Advisory Board for Zander Therapeutics, Inc., a veterinary life sciences company and subsidiary of...More \232aBrian Devine, retired Chairman of PETCO, a leading pet specialty retailer, has agreed to serve as Chairman of the Business Advisory Board for Zander Therapeutics, Inc., a veterinary life sciences company and subsidiary of...More \232aAraclon Biotech initiates phase II clinical trials of its Alzheimer's vaccine
Araclon Biotech initiates phase II clinical trials of its Alzheimer's vaccine
Araclon Biotech, in which Grifols holds a majority stake, has received approval from the Spanish Agency of Medicinal Products and Medical Devices to begin phase II clinical trials for its active immunotherapy for...More \232aAraclon Biotech, in which Grifols holds a majority stake, has received approval from the Spanish Agency of Medicinal Products and Medical Devices to begin phase II clinical trials for its active immunotherapy for...More \232aRegeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union
Regeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has granted marketing authorization for Kevzara® (sarilumab) in combination with methotrexate (MTX) for the...More \232aRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has granted marketing authorization for Kevzara® (sarilumab) in combination with methotrexate (MTX) for the...More \232aMedX Partners With Govsphere to Develop New Software Platform for Medical Lumbar and Cervical Extension Machines
MedX Partners With Govsphere to Develop New Software Platform for Medical Lumbar and Cervical Extension Machines
MedX Holdings, Inc., the manufacturer and global distributor of MedX - branded medical strengthening, testing and rehabilitation equipment, today announced that it has partnered with Govsphere, Inc., a leading developer of...More \232aMedX Holdings, Inc., the manufacturer and global distributor of MedX - branded medical strengthening, testing and rehabilitation equipment, today announced that it has partnered with Govsphere, Inc., a leading developer of...More \232aAdvisory - Unauthorized "Jupiter" and "Kratom Zone" kratom products seized from two Edmonton stores
Advisory - Unauthorized "Jupiter" and "Kratom Zone" kratom products seized from two Edmonton stores
OTTAWA, June 26, 2017 /CNW/ -More \232aOTTAWA, June 26, 2017 /CNW/ -More \232aThe Lieber Institute for Brain Development Establishes the World's Largest Posttraumatic Stress Disorder Postmortem Brain Repository
The Lieber Institute for Brain Development Establishes the World's Largest Posttraumatic Stress Disorder Postmortem Brain Repository
The Lieber Institute for Brain Development (LIBD), an affiliate of the Johns Hopkins University School of Medicine, announced today the establishment of the world's largest collection of postmortem human brains with a...More \232aThe Lieber Institute for Brain Development (LIBD), an affiliate of the Johns Hopkins University School of Medicine, announced today the establishment of the world's largest collection of postmortem human brains with a...More \232aExpansion of Successful Online Population Health Resource Gives U.S. Cities Access to Key Health Data
Expansion of Successful Online Population Health Resource Gives U.S. Cities Access to Key Health Data
Hundreds of United States cities will be able to identify their most pressing health needs more accurately-thanks to a nationwide expansion of the City Health Dashboard, an innovative health data visualization tool.More \232aHundreds of United States cities will be able to identify their most pressing health needs more accurately-thanks to a nationwide expansion of the City Health Dashboard, an innovative health data visualization tool.More \232aThe global market for Single-use Technologies in Biopharmaceuticals expected to reach $4.3 billion by 2021
The global market for Single-use Technologies in Biopharmaceuticals expected to reach $4.3 billion by 2021
HighlightsMore \232aHighlightsMore \232aGovernment of Canada Appoints Chief Public Health Officer
Government of Canada Appoints Chief Public Health Officer
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliatedMore \232aInformation contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliatedMore \232aNYU Langone and BioLabs Launch Center for Biotech Startups in Manhattan
NYU Langone and BioLabs Launch Center for Biotech Startups in Manhattan
NYU Langone Medical Center today announced its plan to launch a large-scale biotech "incubator" in Manhattan, which will begin hosting companies at the end of 2017.More \232aNYU Langone Medical Center today announced its plan to launch a large-scale biotech "incubator" in Manhattan, which will begin hosting companies at the end of 2017.More \232aGlobal Neurosurgical Products Market to Grow at a CAGR of 10.5% by 2023 - Analysis By Product Type, End Users & Region - Research and Markets
Global Neurosurgical Products Market to Grow at a CAGR of 10.5% by 2023 - Analysis By Product Type, End Users & Region - Research and Markets
Research and Markets has announced the addition of the "Global Neurosurgical Products Market: Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering. The Global Neurosurgical Devices Market is...More \232aResearch and Markets has announced the addition of the "Global Neurosurgical Products Market: Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering. The Global Neurosurgical Devices Market is...More \232aJournal of Emergency Nursing Study Underscores Need for Education and Training to Successfully Identify and Treat Human Trafficking Victims
Journal of Emergency Nursing Study Underscores Need for Education and Training to Successfully Identify and Treat Human Trafficking Victims
Healthcare professionals are in a unique position to identify and rescue victims of human trafficking. Nearly 88 percent of them seek medical treatment during captivity, and of those, 68 percent of them are seen in the...More \232aHealthcare professionals are in a unique position to identify and rescue victims of human trafficking. Nearly 88 percent of them seek medical treatment during captivity, and of those, 68 percent of them are seen in the...More \232anThrive named 2017 CMS-Approved Qualified Data Registry
nThrive named 2017 CMS-Approved Qualified Data Registry
nThrive has been designated as a Qualified Registry for MIPS data submission by the Centers for Medicare and Medicaid Services (CMS). As a qualified registry, nThrive will report MIPS measures and monitor activities data...More \232anThrive has been designated as a Qualified Registry for MIPS data submission by the Centers for Medicare and Medicaid Services (CMS). As a qualified registry, nThrive will report MIPS measures and monitor activities data...More \232aCareSource to Begin Serving Medicaid Market in Georgia July 1, 2017
CareSource to Begin Serving Medicaid Market in Georgia July 1, 2017
CareSource, a nationally recognized nonprofit health plan, will begin serving the Georgia Medicaid population July 1, 2017. CareSource will serve Georgia Families® members enrolled in Medicaid and PeachCare for Kids® and...More \232aCareSource, a nationally recognized nonprofit health plan, will begin serving the Georgia Medicaid population July 1, 2017. CareSource will serve Georgia Families® members enrolled in Medicaid and PeachCare for Kids® and...More \232aCureVac Expands GMP Production Capacities for RNA Products
CureVac Expands GMP Production Capacities for RNA Products
CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced during a public open door event at its main location in Tübingen, Germany, on June 24 the extension of its GMP...More \232aCureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced during a public open door event at its main location in Tübingen, Germany, on June 24 the extension of its GMP...More \232aDragonfly Therapeutics Appoints World Leader in NK Therapeutics as Chief Scientific Officer
Dragonfly Therapeutics Appoints World Leader in NK Therapeutics as Chief Scientific Officer
Dragonfly Therapeutics, Inc. ("Dragonfly"), today announced Dr. Nicolai Wagtmann has become its Chief Scientific Officer ("CSO"). Dr. Wagtmann will head the company's scientific team and the development and...More \232aDragonfly Therapeutics, Inc. ("Dragonfly"), today announced Dr. Nicolai Wagtmann has become its Chief Scientific Officer ("CSO"). Dr. Wagtmann will head the company's scientific team and the development and...More \232a6,000 Employees in More Than 50 Countries Join Together as #AbbVieGivesBack
6,000 Employees in More Than 50 Countries Join Together as #AbbVieGivesBack
AbbVie, a global biopharmaceutical company, and its key partners celebrate the launch of the fourth annual "Week of Possibilities," with more than 6,000 employees expected to volunteer 26,000+ hours in the communities...More \232aAbbVie, a global biopharmaceutical company, and its key partners celebrate the launch of the fourth annual "Week of Possibilities," with more than 6,000 employees expected to volunteer 26,000+ hours in the communities...More \232aBruker Announces Novel NMR Phenomics Research Capabilities
Bruker Announces Novel NMR Phenomics Research Capabilities
At the Metabolomics Society Meeting 2017, Bruker announces a new solution for the quantification of metabolites in urine using Nuclear Magnetic Resonance (NMR). Urine metabolic analysis is particularly valuable and...More \232aAt the Metabolomics Society Meeting 2017, Bruker announces a new solution for the quantification of metabolites in urine using Nuclear Magnetic Resonance (NMR). Urine metabolic analysis is particularly valuable and...More \232aEdify Lab Creates and Unveils a Diverse Way For Top Advisors To Obtain Clientele Worldwide
Edify Lab Creates and Unveils a Diverse Way For Top Advisors To Obtain Clientele Worldwide
Curious minds can ask live questions pertaining to various issues, needs, and interests; from mental health, to yoga, environmental engineering, automotive, career advice, contract legality; name it, the specialty exists....More \232aCurious minds can ask live questions pertaining to various issues, needs, and interests; from mental health, to yoga, environmental engineering, automotive, career advice, contract legality; name it, the specialty exists....More \232aMedical Marijuana, Inc. Major Investment AXIM Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment
Medical Marijuana, Inc. Major Investment AXIM Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC QB: AXIM), a world...More \232aMedical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC QB: AXIM), a world...More \232aAcute Heart Failure Treatment Dominated by Therapies Effective at Relieving Symptoms
Acute Heart Failure Treatment Dominated by Therapies Effective at Relieving Symptoms
Decision Resources Group finds that, in the absence of therapies able to improve long-term outcomes, treatment approaches in Acute Heart Failure (AHF) focus mainly on relieving patient symptoms. Loop diuretics, deemed the...More \232aDecision Resources Group finds that, in the absence of therapies able to improve long-term outcomes, treatment approaches in Acute Heart Failure (AHF) focus mainly on relieving patient symptoms. Loop diuretics, deemed the...More \232aVeterinary Immunity and Major Animal Cruelty Changes to Become Law
Veterinary Immunity and Major Animal Cruelty Changes to Become Law
The Pennsylvania Veterinary Medical Association (PVMA) is excited to announce that House Bill (HB) 1238, passed the Senate unanimously last week and now heads to Governor Wolf for his signature. Thank you to Representative...More \232aThe Pennsylvania Veterinary Medical Association (PVMA) is excited to announce that House Bill (HB) 1238, passed the Senate unanimously last week and now heads to Governor Wolf for his signature. Thank you to Representative...More \232aTraceLink Announces End-to-End Administration for Product Track, Alleviating Time-Intensive DSCSA Compliance Tasks for U.S. Hospitals and Pharmacies
TraceLink Announces End-to-End Administration for Product Track, Alleviating Time-Intensive DSCSA Compliance Tasks for U.S. Hospitals and Pharmacies
TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced end-to-end...More \232aTraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced end-to-end...More \232a8th International Breast Densitometry and Cancer Risk Assessment Conference - Breakthrough therapy to reduce mammographic breast density
8th International Breast Densitometry and Cancer Risk Assessment Conference - Breakthrough therapy to reduce mammographic breast density
Dr. Stephen N. Birrell MD PhD presented breakthrough findings into the reduction of mammographic breast density at the 8th International Breast Densitometry and Cancer Risk Assessment Conference in San Francisco,...More \232aDr. Stephen N. Birrell MD PhD presented breakthrough findings into the reduction of mammographic breast density at the 8th International Breast Densitometry and Cancer Risk Assessment Conference in San Francisco,...More \232aSinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction
Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction
Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has entered into a definitive amalgamation agreement (the "Amalgamation...More \232aSinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has entered into a definitive amalgamation agreement (the "Amalgamation...More \232aDebbie's Dream Foundation: Curing Stomach Cancer Encourages Stomach Cancer Researchers to Apply for Peer Reviewed Cancer Research Program Grants
Debbie's Dream Foundation: Curing Stomach Cancer Encourages Stomach Cancer Researchers to Apply for Peer Reviewed Cancer Research Program Grants
For the fifth consecutive year, Debbie's Dream Foundation: Curing Stomach Cancer (DDF) advocates were on Capitol Hill as part of DDF's Annual Advocacy Day to ask members of Congress to support an increased federal...More \232aFor the fifth consecutive year, Debbie's Dream Foundation: Curing Stomach Cancer (DDF) advocates were on Capitol Hill as part of DDF's Annual Advocacy Day to ask members of Congress to support an increased federal...More \232aBiocept Added to the Russell Microcap Index
Biocept Added to the Russell Microcap Index
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that is has...More \232aBiocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that is has...More \232aQ BioMed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team
Q BioMed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization team. Mr. Manuele is a results-oriented, innovative...More \232aQ BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization team. Mr. Manuele is a results-oriented, innovative...More \232a
PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire
